Table 1.

Effect of Ad.DF3-tk Transduction and GCV Treatment on the Growth of Normal Human Hematopoietic Progenitor Cells

Cell Treatment BFU-E*CFU-GM*
BM MNC Control 165 ± 0  400 ± 0  
 Ad.DF3-tk(MOI = 10)  225 ± 20  375 ± 15  
 GCV (50 μmol/L)  205 ± 10  350 ± 10 
 Ad.DF3-tk (MOI = 10) + GCV (50 μmol/L) 220 ± 0  440 ± 0  
RPMI 8226 Control 1-153 1-153 
 Ad.DF3-tk(MOI = 10) + GCV (50 μmol/L)  240 ± 351-155 315 ± 451-155 
Cell Treatment BFU-E*CFU-GM*
BM MNC Control 165 ± 0  400 ± 0  
 Ad.DF3-tk(MOI = 10)  225 ± 20  375 ± 15  
 GCV (50 μmol/L)  205 ± 10  350 ± 10 
 Ad.DF3-tk (MOI = 10) + GCV (50 μmol/L) 220 ± 0  440 ± 0  
RPMI 8226 Control 1-153 1-153 
 Ad.DF3-tk(MOI = 10) + GCV (50 μmol/L)  240 ± 351-155 315 ± 451-155 

Bone marrow MNCs (2 × 105 cells/well) without (

) or with (

) contaminating (1%) RPMI 8226 MM cells were transduced in duplicate with Ad. DF3-tk at MOI = 10 for 2 hours, washed out for 10 hours, and then treated with GCV (50 μmol/L) for 24 hours. CFU-GM and BFU-E colonies were enumerated after 14 days of culture in Iscove’s methylcellulose medium.

*

Expressed as colonies per 1 × 106 cells.

F1-153

RPMI 8226 MM cells overgrew as a monolayer.

F1-155

There were no visible RPMI 8226 MM cells.

or Create an Account

Close Modal
Close Modal